This pilot, double-blind, randomized, placebo-controlled study is aimed at evaluating the effectiveness of low-level laser therapy (LLLT) as a complementary treatment to complete decongestive therapy (CDT) treating lymphedema among breast cancer patients for 12 months post-intervention. Study population was breast cancer patients who were diagnosed and referred to lymphedema clinic for CDT. Participants (n = 22) were randomized and assigned into either an active laser intervention group or an inactive laser placebo-control group. Active LLLT was administered to participants twice a week at the beginning of each CDT session. Outcome measures included lymphedema symptoms, symptom distress, and limb volume by an infrared perometer. Participants in the active and placebo laser groups were comparable in demographic and clinical predictors of lymphedema. In comparison with the placebo group (83.3%), significantly fewer participants in the active laser group (55.6%) reported more than one lymphedema symptom (p = 0.012) at 12 months post-intervention. Significantly, more patients in the active laser group (44.4%) reported less than two impaired limb mobility symptoms in comparison with the placebo group (33.3%) at 12 months post-intervention (p = 0.017). The active laser group had statistically significant improvements in symptom distress of sadness (p = 0.005) from 73 to 11% and self-perception (p = 0.030) from 36 to 0% over time from baseline to 12-months post-intervention. There was no significant reduction in limb volume. Findings of the trial demonstrated significant benefits of complementary LLLT for relieving symptoms and improvement of emotional distress in breast cancer patients with lymphedema.
Keywords: Breast cancer; Low-level laser; Lymphedema; Quality of life; Symptoms.
A pilot randomized trial evaluating low-level laser therapy as an alternative treatment to manual lymphatic drainage for breast cancer-related lymphedema.Oncol Nurs Forum. 2013 Jul;40(4):383-93. doi: 10.1188/13.ONF.383-393. Oncol Nurs Forum. 2013. PMID: 23803270 Free PMC article. Clinical Trial.
Low level laser therapy for the management of breast cancer-related lymphedema: A randomized controlled feasibility study.Lasers Surg Med. 2018 Sep;50(9):924-932. doi: 10.1002/lsm.22947. Epub 2018 May 30. Lasers Surg Med. 2018. PMID: 29851090 Clinical Trial.
Manual lymphatic drainage for lymphedema following breast cancer treatment.Cochrane Database Syst Rev. 2015 May 21;(5):CD003475. doi: 10.1002/14651858.CD003475.pub2. Cochrane Database Syst Rev. 2015. PMID: 25994425 Free PMC article. Review.
Treatment of postmastectomy lymphedema with low-level laser therapy: a double blind, placebo-controlled trial.Cancer. 2003 Sep 15;98(6):1114-22. doi: 10.1002/cncr.11641. Cancer. 2003. PMID: 12973834 Clinical Trial.
Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis.J Cancer Surviv. 2015 Jun;9(2):287-304. doi: 10.1007/s11764-014-0411-1. Epub 2014 Nov 29. J Cancer Surviv. 2015. PMID: 25432632 Review.